NASDAQ:CEMI

Chembio Diagnostics Earnings Date, Estimates & History

$2.94
+0.10 (+3.52 %)
(As of 08/2/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.87
$3.11
50-Day Range
$2.06
$5.34
52-Week Range
$2.06
$8.75
Volume4.87 million shs
Average Volume6.82 million shs
Market Capitalization$59.52 million
P/E RatioN/A
Dividend YieldN/A
Beta1.88

Chembio Diagnostics (NASDAQ:CEMI) Earnings Information

Chembio Diagnostics last released its earnings results on May 6th, 2021. The reported ($0.22) EPS for the quarter, topping analysts' consensus estimates of ($0.30) by $0.08. The company earned $8.72 million during the quarter. Chembio Diagnostics has generated ($1.28) earnings per share over the last year (($1.27) diluted earnings per share). Earnings for Chembio Diagnostics are expected to grow in the coming year, from ($0.92) to ($0.86) per share. Chembio Diagnostics has confirmed that its next quarterly earnings report will be published on Thursday, August 5th, 2021. Chembio Diagnostics will be holding an earnings conference call on Thursday, August 5th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 919-882-2331 with passcode "41881".

Chembio Diagnostics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Chembio Diagnostics (NASDAQ:CEMI) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20211($0.30)($0.30)($0.30) 
Q2 20211($0.38)($0.38)($0.38)$

Chembio Diagnostics (NASDAQ CEMI) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
8/5/2021
(Confirmed)
 ($0.38)       
5/6/20213/31/2021($0.30)($0.22)+$0.08($0.22)$8.72 million  
3/10/202112/31/2020($0.28)($0.35)($0.07)($0.35)$10.23 million  
11/5/20209/30/2020($0.24)($0.28)($0.04)($0.28)$10.27 million  
8/6/20206/30/2020($0.33)($0.40)($0.07)($0.38)$4.60 million$5.11 million  
5/4/20203/31/2020($0.23)($0.25)($0.02)($0.21)$6.86 million  
3/12/202012/31/2019($0.25)($0.24)+$0.01($0.23)$6.85 million  
11/7/2019Q3($0.17)($0.22)($0.05)($0.22)$9.72 million  
8/6/2019Q2 2019($0.16)($0.19)($0.03)($0.19)$8.65 million$9.59 million
5/1/20193/31/2019($0.14)($0.14)($0.12)$8.24 million$8.30 million
3/7/201912/31/2018($0.17)($0.21)($0.04)($0.21)$6.74 million$7.60 million  
11/8/20189/30/2018($0.06)($0.16)($0.10)($0.16)$9.38 million
8/8/2018Q2 2018($0.07)($0.12)($0.05)($0.12)$6.94 million$8.72 million
5/9/2018Q1 2018($0.14)($0.0490)+$0.0910($0.05)$6.10 million$7.72 million
3/8/2018Q4 2017($0.10)($0.16)($0.06)($0.16)$5.66 million$5.99 million    
11/8/2017Q3 2017($0.11)($0.05)+$0.06($0.05)$5.65 million$7.59 million
8/9/2017Q2 2017($0.1650)($0.18)($0.0150)($0.18)$4.96 million$2.89 million  
5/9/2017Q1 2017($0.1950)($0.1320)+$0.0630($0.13)$4.88 million$5.43 million  
3/7/2017Q4 2016($0.15)($0.21)($0.06)($0.21)$4.44 million$4.26 million  
11/10/2016Q3 2016($0.17)($0.19)($0.02)($0.19)$3.76 million$3.75 million
8/11/2016Q2($0.11)($0.86)($0.75)$0.38$6.72 million$3.27 million  
5/12/2016Q1($0.09)($0.03)+$0.06($0.03)$4.83 million$6.60 million  
3/8/2016Q4($0.09)($0.07)+$0.02($0.07)$6.56 million$4.42 million
11/12/2015Q3($0.09)($0.05)+$0.04($0.05)$6.77 million$6.89 million  
8/6/2015Q2($0.03)($0.07)($0.04)($0.07)$7.53 million$6.72 million
5/7/2015Q115($0.08)($0.07)+$0.01($0.07)$5.20 million$6.20 million
3/5/2015Q414($0.04)($0.05)($0.01)($0.05)$7.10 million$7.10 million
11/6/2014Q3 2014($0.03)($0.03)($0.03)$7.71 million$7.31 million
8/7/2014Q2($0.02)($0.02)($0.02)$6.25 million$7.42 million
5/8/2014Q1 2014($0.02)($0.02)($0.02)$6.87 million$5.81 million
3/6/2014Q4 2013$0.04($0.03)($0.07)($0.03)$7.05 million$7.86 million
11/7/2013Q3 2013$0.06$0.07+$0.01$0.07$8.59 million$9.62 million
8/8/2013Q2 2013($0.02)($0.03)($0.01)($0.03)$5.56 million$5.39 million  
5/9/2013Q1 2013$0.06$0.04($0.02)$0.04$7.47 million$6.31 million
3/7/2013Q4 2012$0.07$0.06($0.01)$0.06
11/13/2012Q312$0.04($0.04)($0.08)$6.11 million$5.01 million  
8/9/2012$0.05$0.04($0.01)
5/8/2012Q1 2012$0.08$0.05($0.03)$0.05
3/8/2012Q4 2011$0.08$0.06($0.02)($0.54)
11/3/2011Q3 2011$0.06+$0.06$0.06
8/4/2011Q2 2011$0.02+$0.02$0.02
5/5/2011Q1 2011($0.02)($0.02)($0.02)
3/3/2011Q4 2010$0.22+$0.22$0.22
11/4/2010Q3 2010$0.02+$0.02$0.02
7/29/2010Q2 2010($0.08)$0.07+$0.15$0.07
5/6/2010Q1 2010($0.02)($0.02)($0.02)
3/5/2010Q4 2009$0.02+$0.02$0.02
11/4/2009Q3 2009$0.03+$0.03$0.03
5/8/2009Q1 2009($0.08)($0.08)($0.08)
11/12/2008Q3 2008($0.08)($0.03)+$0.05($0.03)
8/4/2008Q2 2008($0.08)($0.08)($0.08)
3/13/2008Q4 2007($0.80)($2.56)($1.76)($2.56)
(Earnings results data provided by Zacks Investment Research)
speech bubbles
speech bubbles











Chembio Diagnostics (NASDAQ:CEMI) Earnings Frequently Asked Questions

When will Chembio Diagnostics announce their next quarterly earnings?

Chembio Diagnostics has confirmed that its next quarterly earnings data will be published on Thursday, August 5th, 2021. Learn more on CEMI's earnings history

When did Chembio Diagnostics announce their last quarterly earnings?

Chembio Diagnostics (NASDAQ:CEMI) last announced its quarterly earning data on Thursday, May 6, 2021. Learn more on CEMI's earnings history

Did Chembio Diagnostics beat their earnings estimates last quarter?

In the previous quarter, Chembio Diagnostics (NASDAQ:CEMI) reported ($0.22) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.30) by $0.08. Learn more on CEMI's earnings details

How can I read Chembio Diagnostics's conference call transcript?

The conference call transcript for Chembio Diagnostics's latest earnings report can be read online. Read Transcript

How much revenue does Chembio Diagnostics generate each year?

Chembio Diagnostics (NASDAQ:CEMI) has a recorded annual revenue of $32.47 million.

How much profit does Chembio Diagnostics generate each year?

Chembio Diagnostics (NASDAQ:CEMI) has a recorded net income of -$25.52 million. CEMI has generated -$1.28 earnings per share over the last four quarters.

What is Chembio Diagnostics's EPS forecast for next year?

Chembio Diagnostics's earnings are expected to grow from ($0.92) per share to ($0.86) per share in the next year.

This page was last updated on 8/3/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.